Thomas Equals
Chief Executive Officer
Replay available
AIM ImmunoTech Inc. (AMEX: AIM) Q3 2024 earnings conference call, held 2024-11-15. Replay captured from the company's public earnings webcast.

Chief Executive Officer
Scientific Officer
Analyst, Maxim Group
Analyst, Ascending Capital Markets
Watch the replay and follow the connected company analysis, news, and investor updates for Aim Immunotech Inc..
WEBVTT 00:00:00.492 -- 00:00:05.675 Hello, and welcome to the AIM Immunotech third quarter 2024 update conference call 00:00:05.675 -- 00:00:07.216 and webcast. 00:00:07.216 -- 00:00:11.679 As a brief reminder, all participants are currently in a listen-only mode. 00:00:11.679 -- 00:00:16.241 If anyone requires operator assistance during the event, please press star zero on your 00:00:16.241 -- 00:00:18.223 telephone keypad. 00:00:18.223 -- 00:00:21.785 Following the presentation, there will be a question and answer session. 00:00:21.785 -- 00:00:25.607 Note that this webcast is being recorded at the company's request, and a replay will 00:00:25.607 -- 00:00:30.327 be made available on the company's website following the end of the event. 00:00:30.327 -- 00:00:34.070 At this time, I'd like to remind our listeners that remarks made during this webcast 00:00:34.070 -- 00:00:39.034 may state management's intentions, beliefs, expectations, or future projections. 00:00:39.034 -- 00:00:42.757 These are forward-looking statements that involve risks and uncertainties. 00:00:42.757 -- 00:00:46.560 Forward-looking statements on this call are made pursuant to the safe harbor provisions 00:00:46.560 -- 00:00:50.764 of the federal securities laws and are based on AIM Immunotech's current expectations 00:00:50.764 -- 00:00:53.506 and actual results could differ materially. 00:00:53.506 -- 00:00:57.967 As a result, you should not place undue reliance on any forward-looking statements. 00:00:57.967 -- 00:01:02.010 Some of the factors that could cause actual results to differ materially from these contemplated 00:01:02.010 -- 00:01:05.992 by such forward-looking statements are discussed in the periodic reports AIM Immunotech 00:01:05.992 -- 00:01:08.714 files with the Securities and ...